To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 4, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 8, 2024

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CKD-383(Fed)

After maintaining NPO for at least 10 hours before a high-fat meal, take a high-fat meal within 20 minutes on each medication day, and take CKD-383 two tablets orally with 150 mL of water at room temperature.

DRUG

CKD-383(Fasted)

After maintaining NPO for at least 10 hours before dosing, and take CKD-383 two tablets orally with 150 mL of room temperature water with 30g of sugar added on each dosing day.

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY